Nanomedicine targets stomach cancer

Researchers at Israel’s Technion Institute have developed a nanomedicine technology for the targeted treatment of gastric tumors.  The platform combines anti-cancer and anti-resistance compounds, packaged orally in beta-casein – a constituent of mother’s milk.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *